1
|
Wang D, Gu X, Fang K, Fu B, Liu Y, Di X. Study on quality control of Zuojin pill by HPLC fingerprint with quantitative analysis of multi-components by single marker method and antioxidant activity analysis. J Pharm Biomed Anal 2023; 225:115075. [PMID: 36603393 DOI: 10.1016/j.jpba.2022.115075] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/05/2022] [Revised: 09/22/2022] [Accepted: 09/23/2022] [Indexed: 11/06/2022]
Abstract
Current quality control methods for Zuojin Pill (ZJP) lack comprehensiveness and practicability. This study aimed to develop a comprehensive strategy for the quality evaluation of ZJP and the prediction of potential bioactive components in ZJP. First, an HPLC method with excellent separation of main components was developed and was used to establish the chromatographic fingerprint of ZJP. Similarities were calculated by comparing 28 batches of ZJPs with the reference fingerprint and the resulting similarity values were all greater than 0.976. The 28 samples were classified into different groups according to their origins by Hierarchical Cluster Analysis, Principal component analysis, and orthogonal partial least squares discriminant analysis. Based on the classification, eight quality markers (Q-Markers) affecting the quality of ZJP were discovered. Then, using berberine as an internal standard substance, quantitative analysis of multi-components by single marker method (QAMS) for the determination of eight Q-markers was developed. The results showed that there was no significant difference between QAMS and external standard method (P>0.05). Finally, using an off-line antioxidant system and partial least-squares model (PLS), the fingerprint-efficacy relationship of ZJP was constructed to explore and predict the bioactive components in ZJP. The present study strategy could be also applied to comprehensive quality study of other TCMs.
Collapse
|
2
|
Li W, Polachi N, Wang X, Chu Y, Wang Y, Tian M, Li D, Zhou D, Zhou S, Ju A, Li Y, Zhang Y, Chen M, Huang L, Liu C. A quality marker study on salvianolic acids for injection. Phytomedicine 2018; 44:138-147. [PMID: 29544864 DOI: 10.1016/j.phymed.2018.02.003] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/14/2017] [Revised: 11/22/2017] [Accepted: 02/05/2018] [Indexed: 05/14/2023]
Abstract
BACKGROUND The quality of Chinese medicine (CM) has being an active and challenging research area for CM. Prof. Chang-Xiao Liu et al first proposed the concept of quality marker (Q-Marker) for the quality evaluation and control on CM. This article describe the exploratory studies of Q-Marker in salvianolic acids for injection (SAI) based on this new concept. PURPOSE This study was designed to screen Q-Marker of SAI and establish its quality control method based on the concept of CM Q-Marker. METHODS Based on the concept of CM Q-Marker, the SAI was investigated for the identification of chemical components and their sources. The pharmacological effects on cerebral ischemia and reperfusion induced injury in rats were also investigated. Furthermore, the target cell extracts and pharmacokinetic studies were conducted to screen Q-Markers. Finally, the fingerprints and determination based on Q-Markers were established to assess the quality of SAI more effectively. RESULTS Overall, 20 constituents in SAI were identified. It was found that salvianolic acid B (SA-B), rosmarinic acid (RA), lithospermic acid (LA), salvianolic acid D (SA-D) and salvianolic acid Y (SA-Y) are major chemical components of SAI. Based on chemical components identifications, analysis of their sources, target cell extracts and pharmacokinetic studies, four phenolic acids, namely SA-B, RA, LA and SA-D, were screened and determined as effective Q-Markers of SAI. CONCLUSION This study demonstrated that the described method is a powerful approach for detecting Q-Markers, which can be used as control index for the quality assessment of CM.
Collapse
Affiliation(s)
- Wei Li
- National Resource Center for Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing - 100700, China; Center for Post-doctoral Research, China Academy of Chinese Medical Sciences, Beijing - 100700, China; State Key Laboratory of Core Technology in Innovative Chinese Medicine, Tasly Pharmaceutical Group Co., Ltd., Tianjin - 300410, China; Tasly Academy, Tasly Holding Group Co., Ltd., Tianjin - 300410, China.
| | - Navaneethakrishnan Polachi
- School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin - 300193, China; State Key Laboratory of Core Technology in Innovative Chinese Medicine, Tasly Pharmaceutical Group Co., Ltd., Tianjin - 300410, China; Tasly Academy, Tasly Holding Group Co., Ltd., Tianjin - 300410, China
| | - Xiangyang Wang
- State Key Laboratory of Core Technology in Innovative Chinese Medicine, Tasly Pharmaceutical Group Co., Ltd., Tianjin - 300410, China; Tasly Academy, Tasly Holding Group Co., Ltd., Tianjin - 300410, China
| | - Yang Chu
- State Key Laboratory of Core Technology in Innovative Chinese Medicine, Tasly Pharmaceutical Group Co., Ltd., Tianjin - 300410, China; Tasly Academy, Tasly Holding Group Co., Ltd., Tianjin - 300410, China
| | - Yuan Wang
- School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin - 300193, China; State Key Laboratory of Core Technology in Innovative Chinese Medicine, Tasly Pharmaceutical Group Co., Ltd., Tianjin - 300410, China; Tasly Academy, Tasly Holding Group Co., Ltd., Tianjin - 300410, China
| | - Meng Tian
- School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin - 300193, China; State Key Laboratory of Core Technology in Innovative Chinese Medicine, Tasly Pharmaceutical Group Co., Ltd., Tianjin - 300410, China; Tasly Academy, Tasly Holding Group Co., Ltd., Tianjin - 300410, China
| | - Dekun Li
- State Key Laboratory of Core Technology in Innovative Chinese Medicine, Tasly Pharmaceutical Group Co., Ltd., Tianjin - 300410, China; Tianjin Tasly Pride Pharmaceutical Co., Ltd., Tianjin - 300410, China
| | - Dazheng Zhou
- State Key Laboratory of Core Technology in Innovative Chinese Medicine, Tasly Pharmaceutical Group Co., Ltd., Tianjin - 300410, China; Tianjin Tasly Pride Pharmaceutical Co., Ltd., Tianjin - 300410, China
| | - Shuiping Zhou
- State Key Laboratory of Core Technology in Innovative Chinese Medicine, Tasly Pharmaceutical Group Co., Ltd., Tianjin - 300410, China; Tasly Academy, Tasly Holding Group Co., Ltd., Tianjin - 300410, China
| | - Aichun Ju
- State Key Laboratory of Core Technology in Innovative Chinese Medicine, Tasly Pharmaceutical Group Co., Ltd., Tianjin - 300410, China; Tianjin Tasly Pride Pharmaceutical Co., Ltd., Tianjin - 300410, China
| | - Yubo Li
- School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin - 300193, China
| | - Yanjun Zhang
- School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin - 300193, China
| | - Min Chen
- National Resource Center for Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing - 100700, China; Center for Post-doctoral Research, China Academy of Chinese Medical Sciences, Beijing - 100700, China
| | - Luqi Huang
- National Resource Center for Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing - 100700, China; Center for Post-doctoral Research, China Academy of Chinese Medical Sciences, Beijing - 100700, China.
| | - Changxiao Liu
- The State Key Laboratory of Drug Delivery Technology and Pharmacokinetics, Tianjin Institute of Pharmaceutical Research, Tianjin - 300193, China.
| |
Collapse
|